Learning From Cervical Cancer Survivors: An Examination of Barriers and Facilitators to Cervical Cancer Screening Among Women in the United States.

Virginia Senkomago, April Greek, J Elizabeth Jackson, Cheryll C Thomas, Lisa C Richardson, Vicki B Benard
Author Information
  1. Virginia Senkomago: Centers for Disease Control and Prevention, Atlanta, GA, USA. ORCID
  2. April Greek: Battelle, Seattle, WA, USA.
  3. J Elizabeth Jackson: Battelle, Seattle, WA, USA.
  4. Cheryll C Thomas: Centers for Disease Control and Prevention, Atlanta, GA, USA.
  5. Lisa C Richardson: Centers for Disease Control and Prevention, Atlanta, GA, USA.
  6. Vicki B Benard: Centers for Disease Control and Prevention, Atlanta, GA, USA.

Abstract

BACKGROUND: Screening and timely follow-up have lowered cervical cancer incidence in the US; however, screening coverage, incidence, and death rates have remained fairly stable in recent years. Studies suggest that half of women diagnosed with cervical cancer don't receive appropriate screening prior to diagnosis; cervical cancer survivors can provide crucial insight into barriers and facilitators to screening.
METHODS: Participants were cervical cancer survivors ≥21 years, identified through population-based central cancer registries (CR) in 3 US states or a social network (SN), Cervivor. CR Participants completed a mailed survey on screening history, barriers, and facilitators to screening and sociodemographic data. SN Participants completed the same survey online.
RESULTS: CR Participants (N = 480) were older, with a lower proportion of non-Hispanic white, married, and insured women compared to SN Participants (N = 148). Fifty percent of CR and 79% of SN Participants were screened 5 years prior to their diagnoses. Of those screened, 28% in both groups reported not following-up on abnormal results. For both groups, the most frequently identified screening barrier was that Participants never imagined they would develop cervical cancer (percent agree CR = 76%; SN = 86%), and the facilitator was wanting to take care of their bodies (CR = 95%; SN = 94%).
CONCLUSION: Addressing key barriers to obtaining screening and timely follow-up related to lack of knowledge of cervical cancer risk and screening tests and addressing insurance coverage in the design or modification of interventions may increase cervical cancer screening and lower cervical cancer incidence in the US.

Keywords

References

  1. Prev Chronic Dis. 2013 Oct 24;10:E173 [PMID: 24157076]
  2. Cancer Med. 2021 Jun;10(12):4127-4137 [PMID: 34018674]
  3. MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):981-985 [PMID: 28934183]
  4. J Am Geriatr Soc. 2008 Feb;56(2):307-14 [PMID: 18070002]
  5. Prev Chronic Dis. 2014 Feb 27;11:E29 [PMID: 24576396]
  6. Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):529-34 [PMID: 12050093]
  7. MMWR Morb Mortal Wkly Rep. 2017 Mar 03;66(8):201-206 [PMID: 28253225]
  8. Cancer. 2014 Aug 15;120 Suppl 16:2591-6 [PMID: 25099902]
  9. J Womens Health (Larchmt). 2011 Nov;20(11):1579-85 [PMID: 21933006]
  10. J Community Health. 2012 Feb;37(1):217-23 [PMID: 21773819]
  11. J Natl Cancer Inst. 2005 May 4;97(9):675-83 [PMID: 15870438]
  12. J Womens Health (Larchmt). 2014 Jun;23(6):488-92 [PMID: 24707839]
  13. J Low Genit Tract Dis. 2008 Jul;12(3):232-41 [PMID: 18596467]
  14. Cancer Causes Control. 2015 May;26(5):687 [PMID: 25929885]
  15. Cancer. 2000 May 15;88(10):2283-9 [PMID: 10820350]
  16. J Immigr Minor Health. 2019 Jun;21(3):606-658 [PMID: 30117005]
  17. J Womens Health (Larchmt). 2019 Jul;28(7):890-896 [PMID: 31264934]
  18. J Natl Med Assoc. 2005 Feb;97(2):162-70 [PMID: 15712779]
  19. J Womens Health (Larchmt). 2011 Apr;20(4):517-24 [PMID: 21413897]
  20. Gynecol Oncol. 2013 Apr;129(1):222-8 [PMID: 23280088]
  21. J Womens Health (Larchmt). 2013 Sep;22(9):718-23 [PMID: 23930983]
  22. J Community Health. 2017 Aug;42(4):770-778 [PMID: 28155005]
  23. Curr Oncol. 2014 Dec;21(6):294-304 [PMID: 25489256]
  24. J Womens Health (Larchmt). 2014 Mar;23(3):197-203 [PMID: 24380501]

Grants

  1. HHSN261201300016C/NCI NIH HHS
  2. U58 DP003915/NCCDPHP CDC HHS
  3. HHSN261201300021C/NCI NIH HHS
  4. U58 DP003921/NCCDPHP CDC HHS
  5. HHSN261201300016I/NCI NIH HHS

MeSH Term

Cancer Survivors
Early Detection of Cancer
Female
Humans
Mass Screening
Surveys and Questionnaires
United States
Uterine Cervical Neoplasms

Word Cloud

Created with Highcharts 10.0.0cancercervicalscreeningparticipantsbarriersCRSNincidenceUSsurvivorsfacilitatorsScreeningtimelyfollow-upcoveragewomenprioridentifiedregistriescompletedsurveylowerpercentscreenedgroupsCervicalCancerBACKGROUND:loweredhoweverdeathratesremainedfairlystablerecentyearsStudiessuggesthalfdiagnosedreceiveappropriatediagnosiscanprovidecrucialinsightMETHODS:Participants≥21 yearspopulation-basedcentral3statessocialnetworkCervivormailedhistorysociodemographicdataonlineRESULTS:N = 480olderproportionnon-HispanicwhitemarriedinsuredcomparedN = 148Fifty79%5 yearsdiagnoses28%reportedfollowing-upabnormalresultsfrequentlybarrierneverimagineddevelopagreeCR = 76%SN = 86%facilitatorwantingtakecarebodiesCR = 95%SN = 94%CONCLUSION:AddressingkeyobtainingrelatedlackknowledgerisktestsaddressinginsurancedesignmodificationinterventionsmayincreaseLearningSurvivors:ExaminationBarriersFacilitatorsAmongWomenUnitedStates

Similar Articles

Cited By